Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Apr 2;20(1):156.
doi: 10.1186/s13023-025-03686-4.

The relationship between adult phenylketonuria and the cardiovascular system - insights into mechanisms and risks

Affiliations
Review

The relationship between adult phenylketonuria and the cardiovascular system - insights into mechanisms and risks

Yann Dos Santos et al. Orphanet J Rare Dis. .

Abstract

Studies in adults with PKU have mainly focused on the neuropsychiatric complications that may arise in individuals who are unable to maintain the recommended lifetime diet. Some recent epidemiological studies suggest to consider other complications. As such, cardiovascular (CV) issues have been the subject of few studies to date. The aim of this review is to gather and discuss data from the literature on the traditional risks of CV complications in PKU, a potential CV phenotype in this population and the various non-traditional risks and potential associated mechanisms. The reported prevalence of comorbidities suggests an increased risk of CV complications in adults with PKU, mostly in late-diagnosed patients. Studies about a specific CV phenotype associated with PKU are suggestive, although further studies are needed. The data on oxidative stress in this population are consistent and confirm an increased CV risk. Regarding other potential mechanisms, it is not possible to conclude whether adult PKU patients have low grade inflammation, dyslipidemia, kidney impairment or if they have hyperhomocysteinemia. It would be of interest to measure potential biomarker associated with CV complications, such as homocysteine, asymmetric dimethylarginine and kynurenines (quinolic acid).

Keywords: Adults; Cardiovascular disease; Phenylketonuria.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flowchart showing article selection process. Based on title, articles not in English or dealing solely with children or the maternal syndrome of PKU were excluded. The remaining articles were then selected by reading the abstract or the article itself, when the abstract did not allow us to conclude whether the article was relevant to the subject in question. The remaining articles have been included in the review
Fig. 2
Fig. 2
Summary of results concerning traditional CVD risk and potential associated mechanisms. Heart image comes from BioRender.com

References

    1. Hillert A, Anikster Y, Belanger-Quintana A, et al. The genetic landscape and epidemiology of phenylketonuria. Am J Hum Genet. 2020;107(2):234–50. - PMC - PubMed
    1. Elhawary NA, AlJahdali IA, Abumansour IS, et al. Genetic etiology and clinical challenges of phenylketonuria. Hum Genomics. 2022;16(1):22. Published 2022 Jul 19. - PMC - PubMed
    1. Anikster Y, Haack TB, Vilboux T, et al. Biallelic mutations in DNAJC12 cause hyperphenylalaninemia, dystonia, and intellectual disability. Am J Hum Genet. 2017;100(2):257–66. - PMC - PubMed
    1. Blau N. Genetics of phenylketonuria: then and now. Hum Mutat. 2016;37(6):508–15. - PubMed
    1. van Spronsen FJ, Blau N, Harding C, Burlina A, Longo N, Bosch AM, Phenylketonuria. Nat Rev Dis Primers. 2021;7(1):36. - PMC - PubMed